Johnson & Johnson stock is scheduled to report its Q1 2021 results on Tuesday, April 20. We expect J&J to report revenues and earnings slightly below the consensus estimates. The pharmaceuticals sales will be driven by market share gains for Imbruvica, Darzalex, and Stelara, more than offsetting...
Johnson & Johnson stock is scheduled to report its Q1 2021 results on Tuesday, April 20. We expect J&J to report revenues and earnings slightly below the consensus estimates. The pharmaceuticals sales will be driven by market share gains for Imbruvica, Darzalex, and Stelara, more than offsetting...
Share this Article
Recommended